chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased, Vomiting, White blood cell count increased
Clinical narrative: PRESENTING PROBLEM: Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC)    HOSPITAL COURSE: Patient is an 83 y.o. male with history of oxygen-dependent COPD (on 2 L oxygen at baseline), stage IV adenocarcinoma of the left lung on chemotherapy, chronic pain, paroxysmal atrial fibrillation, and recent hospitalization for COVID-19 who presented with increased shortness of breath and nausea with vomiting. Symptoms started about 1-2 hours after eating chili and fries at a restaurant. Had frequent vomiting, was eventually placed on BIPAP per EMS then weaned to nasal cannula. Work-up did reveal elevated lactic acid, respiratory acidosis (pH 7.21, pCO2 69), WBC count 27.7, hsTnT 25-33.  Chest x-ray suggested patchy infiltrate in left lung base suggestive of pneumonia and small layering left pleural effusion (present previously).  He was started on IV Cefepime and IV Vancomycin and improved clinically with a 5-day course. He did have abdominal pain that improved with Maalox. He was evaluated by SLP who performed a videofluroscopy swallow study which showed mild-moderate pharyngeal dysphagia and aspiration with thin liquids. He was recommended general solids, thin liquids, liquids by cup, no straws, meds in appelsauce and strategies for safe oral intake including chin tuck, upright for all intake, repeat swallow, small bites and small sips. Patient had no further abdominal pain. He was clinically improved and discharged in stable condition.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Acute respiratory failure, Aspiration, Barium swallow, Blood lactic acid increased
Clinical narrative: PRESENTING PROBLEM: Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC)    HOSPITAL COURSE: Patient is an 83 y.o. male with history of oxygen-dependent COPD (on 2 L oxygen at baseline), stage IV adenocarcinoma of the left lung on chemotherapy, chronic pain, paroxysmal atrial fibrillation, and recent hospitalization for COVID-19 who presented with increased shortness of breath and nausea with vomiting. Symptoms started about 1-2 hours after eating chili and fries at a restaurant. Had frequent vomiting, was eventually placed on BIPAP per EMS then weaned to nasal cannula. Work-up did reveal elevated lactic acid, respiratory acidosis (pH 7.21, pCO2 69), WBC count 27.7, hsTnT 25-33.  Chest x-ray suggested patchy infiltrate in left lung base suggestive of pneumonia and small layering left pleural effusion (present previously).  He was started on IV Cefepime and IV Vancomycin and improved clinically with a 5-day course. He did have abdominal pain that improved with Maalox. He was evaluated by SLP who performed a videofluroscopy swallow study which showed mild-moderate pharyngeal dysphagia and aspiration with thin liquids. He was recommended general solids, thin liquids, liquids by cup, no straws, meds in appelsauce and strategies for safe oral intake including chin tuck, upright for all intake, repeat swallow, small bites and small sips. Patient had no further abdominal pain. He was clinically improved and discharged in stable condition.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pH decreased, Chest X-ray abnormal, Dysphagia, Dyspnoea, Lung infiltration
Clinical narrative: PRESENTING PROBLEM: Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC)    HOSPITAL COURSE: Patient is an 83 y.o. male with history of oxygen-dependent COPD (on 2 L oxygen at baseline), stage IV adenocarcinoma of the left lung on chemotherapy, chronic pain, paroxysmal atrial fibrillation, and recent hospitalization for COVID-19 who presented with increased shortness of breath and nausea with vomiting. Symptoms started about 1-2 hours after eating chili and fries at a restaurant. Had frequent vomiting, was eventually placed on BIPAP per EMS then weaned to nasal cannula. Work-up did reveal elevated lactic acid, respiratory acidosis (pH 7.21, pCO2 69), WBC count 27.7, hsTnT 25-33.  Chest x-ray suggested patchy infiltrate in left lung base suggestive of pneumonia and small layering left pleural effusion (present previously).  He was started on IV Cefepime and IV Vancomycin and improved clinically with a 5-day course. He did have abdominal pain that improved with Maalox. He was evaluated by SLP who performed a videofluroscopy swallow study which showed mild-moderate pharyngeal dysphagia and aspiration with thin liquids. He was recommended general solids, thin liquids, liquids by cup, no straws, meds in appelsauce and strategies for safe oral intake including chin tuck, upright for all intake, repeat swallow, small bites and small sips. Patient had no further abdominal pain. He was clinically improved and discharged in stable condition.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, PCO2 increased, Pleural effusion, Pneumonia, Positive airway pressure therapy
Clinical narrative: PRESENTING PROBLEM: Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC)    HOSPITAL COURSE: Patient is an 83 y.o. male with history of oxygen-dependent COPD (on 2 L oxygen at baseline), stage IV adenocarcinoma of the left lung on chemotherapy, chronic pain, paroxysmal atrial fibrillation, and recent hospitalization for COVID-19 who presented with increased shortness of breath and nausea with vomiting. Symptoms started about 1-2 hours after eating chili and fries at a restaurant. Had frequent vomiting, was eventually placed on BIPAP per EMS then weaned to nasal cannula. Work-up did reveal elevated lactic acid, respiratory acidosis (pH 7.21, pCO2 69), WBC count 27.7, hsTnT 25-33.  Chest x-ray suggested patchy infiltrate in left lung base suggestive of pneumonia and small layering left pleural effusion (present previously).  He was started on IV Cefepime and IV Vancomycin and improved clinically with a 5-day course. He did have abdominal pain that improved with Maalox. He was evaluated by SLP who performed a videofluroscopy swallow study which showed mild-moderate pharyngeal dysphagia and aspiration with thin liquids. He was recommended general solids, thin liquids, liquids by cup, no straws, meds in appelsauce and strategies for safe oral intake including chin tuck, upright for all intake, repeat swallow, small bites and small sips. Patient had no further abdominal pain. He was clinically improved and discharged in stable condition.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory acidosis, Respiratory failure, Troponin T, Vomiting, White blood cell count increased
Clinical narrative: PRESENTING PROBLEM: Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC)    HOSPITAL COURSE: Patient is an 83 y.o. male with history of oxygen-dependent COPD (on 2 L oxygen at baseline), stage IV adenocarcinoma of the left lung on chemotherapy, chronic pain, paroxysmal atrial fibrillation, and recent hospitalization for COVID-19 who presented with increased shortness of breath and nausea with vomiting. Symptoms started about 1-2 hours after eating chili and fries at a restaurant. Had frequent vomiting, was eventually placed on BIPAP per EMS then weaned to nasal cannula. Work-up did reveal elevated lactic acid, respiratory acidosis (pH 7.21, pCO2 69), WBC count 27.7, hsTnT 25-33.  Chest x-ray suggested patchy infiltrate in left lung base suggestive of pneumonia and small layering left pleural effusion (present previously).  He was started on IV Cefepime and IV Vancomycin and improved clinically with a 5-day course. He did have abdominal pain that improved with Maalox. He was evaluated by SLP who performed a videofluroscopy swallow study which showed mild-moderate pharyngeal dysphagia and aspiration with thin liquids. He was recommended general solids, thin liquids, liquids by cup, no straws, meds in appelsauce and strategies for safe oral intake including chin tuck, upright for all intake, repeat swallow, small bites and small sips. Patient had no further abdominal pain. He was clinically improved and discharged in stable condition.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Abdominal pain upper, Arthralgia, Asthenia, Atrioventricular block first degree, Blindness
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Blood glucose increased, Bundle branch block left, COVID-19, Chest X-ray normal, Chest pain
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Cough, Electrocardiogram abnormal, Fatigue, Glycosylated haemoglobin normal, Loss of personal independence in daily activities
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Oedema peripheral, Oxygen saturation decreased, SARS-CoV-2 test positive, Scan myocardial perfusion, Tachypnoea
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Troponin increased, Ultrasound Doppler normal
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Abdominal pain upper, Anticoagulant therapy, Arthralgia, Asthenia, Atrioventricular block first degree
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Blindness, Blood creatinine increased, Blood glucose increased, Bundle branch block left, COVID-19
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Cardiac failure congestive, Chest X-ray abnormal, Chest pain, Computerised tomogram thorax normal, Condition aggravated
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Confusional state, Cough, Death, Diuretic therapy, Dyspnoea
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram abnormal, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Glycosylated haemoglobin normal, Hypoxia, Left ventricular failure, Loss of personal independence in daily activities, Lung opacity
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Oedema peripheral, Orthopnoea, Oxygen saturation decreased, Pleural effusion, Prohormone brain natriuretic peptide increased
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Renal impairment, Respiratory symptom, SARS-CoV-2 test positive, Sinus rhythm, Tachypnoea
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 94.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Troponin increased, Ultrasound Doppler normal, Wheezing
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 11/9/2022 COVID positive date: 11/12/2022 PRESENTING PROBLEM: SOB (shortness of breath) [R06.02] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9]   HOSPITAL COURSE: Pt is a 94 yr old M with PMHX of CAD, ICMP s/p ICD, CKD IIIb, and recent hospitalization with COVID-19 presented to ED with shortness of breath and orthopnea.   Workup in the ED found borderline hypoxia, proBNP level of 7000.  Creatinine was elevated around baseline.  EKG showed a first-degree AV block but no acute ST or T-wave changes.  Chest x-ray showed some mild hazy opacities with trace bilateral pleural effusions.  Patient started on IV lasix and admitted for further management.   Echo done showed LVEF of 31 % (down from 40%).  CT chest showed no large effusion and no significant amount of pulmonary edema and no scarring.    He was treated for Acute on Chronic Combined Systolic and Diastolic CHF with IV lasix in consultation with Cardiology. Also found to have significant wheezing - felt ot be due to post-COVID bronchitis. Started on Duonebs, IV solumedrol, 3% nebulized saline with improvement in his symptoms.His renal function worsened- diuretics held and Nephrology consulted.    Patient developed progressive confusion and respiratory symptoms. DPOA activated (all 3 children). Family decided to pursue Comfort care - they signed on with Hospice on 11/16.   Patient was started on Fentanyl drip for symptomatic management. He passed away peacefully on 11/16/2022 at 1400.
Age: 86.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Wrong product administered
Clinical narrative: Non bivalent booster given.
Age: 86.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Non bivalent booster given.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: Red itchy rash on arms and neck; Red itchy rash on arms and neck; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 81-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 03Nov2022 at 11:30 as dose 5 (booster), single (Lot number: GH9703) at the age of 81 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "known allergies : raw garlic" (unspecified if ongoing); "known allergies :oral narcotics" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 4 (BOOSTER), SINGLE; Lot number: J4989; Vaccination time: 11:30; Anatomical location: Left arm), administration date: 06May2022, when the patient was 80-year-old, for covid-19 immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot number: 30145BA; Vaccination time: 09:45; Anatomical location: Left arm), administration date: 01Oct2021, when the patient was 80-year-old, for covid-19 immunization; BNT162b2 (DOSE 2, SINGLE; Lot number: EN6201; Vaccination time: 08:30; Anatomical location: Left arm), administration date: 20Feb2021, when the patient was 79-year-old, for covid-19 immunization; BNT162b2 (DOSE 1, SINGLE; Lot number: EN9581; Vaccination time: 08:30; Anatomical location: Left arm), administration date: 30Jan2021, when the patient was 79-year-old, for covid-19 immunization. The following information was reported: RASH ERYTHEMATOUS (non-serious), RASH PRURITIC (non-serious) all with onset 04Nov2022 at 08:00, outcome "not recovered" and all described as "Red itchy rash on arms and neck". The events "red itchy rash on arms and neck" required physician office visit. Therapeutic measures were not taken as a result of rash erythematous, rash pruritic.  Additional information: the patient did not had COVID-19 prior vaccination and did not tested post vaccination. The patient did not receive other vaccination in 4 weeks.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Red itchy rash on arms and neck; Red itchy rash on arms and neck; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 81-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 03Nov2022 at 11:30 as dose 5 (booster), single (Lot number: GH9703) at the age of 81 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "known allergies : raw garlic" (unspecified if ongoing); "known allergies :oral narcotics" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 4 (BOOSTER), SINGLE; Lot number: J4989; Vaccination time: 11:30; Anatomical location: Left arm), administration date: 06May2022, when the patient was 80-year-old, for covid-19 immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot number: 30145BA; Vaccination time: 09:45; Anatomical location: Left arm), administration date: 01Oct2021, when the patient was 80-year-old, for covid-19 immunization; BNT162b2 (DOSE 2, SINGLE; Lot number: EN6201; Vaccination time: 08:30; Anatomical location: Left arm), administration date: 20Feb2021, when the patient was 79-year-old, for covid-19 immunization; BNT162b2 (DOSE 1, SINGLE; Lot number: EN9581; Vaccination time: 08:30; Anatomical location: Left arm), administration date: 30Jan2021, when the patient was 79-year-old, for covid-19 immunization. The following information was reported: RASH ERYTHEMATOUS (non-serious), RASH PRURITIC (non-serious) all with onset 04Nov2022 at 08:00, outcome "not recovered" and all described as "Red itchy rash on arms and neck". The events "red itchy rash on arms and neck" required physician office visit. Therapeutic measures were not taken as a result of rash erythematous, rash pruritic.  Additional information: the patient did not had COVID-19 prior vaccination and did not tested post vaccination. The patient did not receive other vaccination in 4 weeks.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Caller had Covid also in Jan2022.; Caller had Covid also in Jan2022.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, as dose 2, single (Batch/Lot number: unknown), in left arm and in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "Caller had Covid also in Jan2022.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Caller had Covid also in Jan2022.; Caller had Covid also in Jan2022.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, as dose 2, single (Batch/Lot number: unknown), in left arm and in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "Caller had Covid also in Jan2022.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE..; HCP reporting a patient was administered a vaccine that was improperly stored.; This spontaneous report was received from a nurse, referring to a patient with unspecified age and gender. The patient's pertinent medical histories, drug reactions/allergies and concomitant medications were not reported.  On 24-OCT-2022, the patient was administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection (0.5 milliliter/ once, lot#: W024973, expiration date: 05-FEB-2024, therapy type: rHA) administered for prophylaxis (strength and route of administration were not provided) that was improperly stored (product storage error). The vaccine was exposed to 18.3 degrees Fahrenheit for 2 hours 16 minutes 0 seconds. Previous excursion included 11.7 degrees Fahrenheit for 1 hour 48 minutes 0 seconds. No additional adverse event was reported (no adverse event).; Sender's Comments:  US-009507513-2211USA001257:same reporter link US-009507513-2211USA001529:same reporter link
Age: 13.0
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No additional AE; PROQUAD was accidently given to a 13 year old patient on 17AUG2022.; This spontaneous report was received from an other health professional who is an educator and refers to a 13-year-old patient of unknown gender.  The patient's pertinent medical history, current conditions, drug reactions or allergies and concomitant medications were not reported.  On 17-AUG-2022, the patient was accidently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided) (product administered to patient of inappropriate age). No additional adverse events details or product quality complaints were reported (no adverse event).
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Asthenia, Blood pressure increased, Constipation, Dizziness
Clinical narrative: 24 hours after vaccine my left arm developed a raised  red, welt that was sore and hot to the touch, I also became extremely lightheaded/dizzy for over 30 days afterward, I had a rapid heart rate (well over 100bpm) that happened numerous times throughout the day even when laying still, BP spikes, weakness all over body - especially left arm, very tired, my right hip became extremely sore at the joint, pins/needles in both hands and feet, nausea, brain fog, constipation, unsteady gait, shakiness, ache behind right eye- all symptoms lasted for at least 30 days.  One month after the vaccination, I developed a strange skin reaction at the injection site where a red line appeared under the skin and there were a few blisters on the surface; the skin eventually turned dark and started to peel, sting and itch for over 1.5 weeks (still like that, but healing).
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Eye pain, Fatigue, Feeling abnormal, Gait disturbance, Heart rate increased
Clinical narrative: 24 hours after vaccine my left arm developed a raised  red, welt that was sore and hot to the touch, I also became extremely lightheaded/dizzy for over 30 days afterward, I had a rapid heart rate (well over 100bpm) that happened numerous times throughout the day even when laying still, BP spikes, weakness all over body - especially left arm, very tired, my right hip became extremely sore at the joint, pins/needles in both hands and feet, nausea, brain fog, constipation, unsteady gait, shakiness, ache behind right eye- all symptoms lasted for at least 30 days.  One month after the vaccination, I developed a strange skin reaction at the injection site where a red line appeared under the skin and there were a few blisters on the surface; the skin eventually turned dark and started to peel, sting and itch for over 1.5 weeks (still like that, but healing).
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site discolouration, Injection site erythema, Injection site pain, Injection site pruritus, Injection site reaction
Clinical narrative: 24 hours after vaccine my left arm developed a raised  red, welt that was sore and hot to the touch, I also became extremely lightheaded/dizzy for over 30 days afterward, I had a rapid heart rate (well over 100bpm) that happened numerous times throughout the day even when laying still, BP spikes, weakness all over body - especially left arm, very tired, my right hip became extremely sore at the joint, pins/needles in both hands and feet, nausea, brain fog, constipation, unsteady gait, shakiness, ache behind right eye- all symptoms lasted for at least 30 days.  One month after the vaccination, I developed a strange skin reaction at the injection site where a red line appeared under the skin and there were a few blisters on the surface; the skin eventually turned dark and started to peel, sting and itch for over 1.5 weeks (still like that, but healing).
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site vesicles, Muscular weakness, Nausea, Paraesthesia, Rash
Clinical narrative: 24 hours after vaccine my left arm developed a raised  red, welt that was sore and hot to the touch, I also became extremely lightheaded/dizzy for over 30 days afterward, I had a rapid heart rate (well over 100bpm) that happened numerous times throughout the day even when laying still, BP spikes, weakness all over body - especially left arm, very tired, my right hip became extremely sore at the joint, pins/needles in both hands and feet, nausea, brain fog, constipation, unsteady gait, shakiness, ache behind right eye- all symptoms lasted for at least 30 days.  One month after the vaccination, I developed a strange skin reaction at the injection site where a red line appeared under the skin and there were a few blisters on the surface; the skin eventually turned dark and started to peel, sting and itch for over 1.5 weeks (still like that, but healing).
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash erythematous, Rash papular, Skin exfoliation, Skin warm, Tremor
Clinical narrative: 24 hours after vaccine my left arm developed a raised  red, welt that was sore and hot to the touch, I also became extremely lightheaded/dizzy for over 30 days afterward, I had a rapid heart rate (well over 100bpm) that happened numerous times throughout the day even when laying still, BP spikes, weakness all over body - especially left arm, very tired, my right hip became extremely sore at the joint, pins/needles in both hands and feet, nausea, brain fog, constipation, unsteady gait, shakiness, ache behind right eye- all symptoms lasted for at least 30 days.  One month after the vaccination, I developed a strange skin reaction at the injection site where a red line appeared under the skin and there were a few blisters on the surface; the skin eventually turned dark and started to peel, sting and itch for over 1.5 weeks (still like that, but healing).
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: 24 hours after vaccine my left arm developed a raised  red, welt that was sore and hot to the touch, I also became extremely lightheaded/dizzy for over 30 days afterward, I had a rapid heart rate (well over 100bpm) that happened numerous times throughout the day even when laying still, BP spikes, weakness all over body - especially left arm, very tired, my right hip became extremely sore at the joint, pins/needles in both hands and feet, nausea, brain fog, constipation, unsteady gait, shakiness, ache behind right eye- all symptoms lasted for at least 30 days.  One month after the vaccination, I developed a strange skin reaction at the injection site where a red line appeared under the skin and there were a few blisters on the surface; the skin eventually turned dark and started to peel, sting and itch for over 1.5 weeks (still like that, but healing).
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blindness, Magnetic resonance imaging head, Neuritis, Optic neuritis, Pain
Clinical narrative: bilateral optic, facial and trigeminal neuritis with pain and vision loss.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Trigeminal neuritis
Clinical narrative: bilateral optic, facial and trigeminal neuritis with pain and vision loss.
Age: 75.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Finally you ask!!!! Terrible aches and fatigue on and off for over 7 weeks!!!
Age: 75.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Head discomfort, Musculoskeletal pain
Clinical narrative: Finally you ask!!!! Terrible aches and fatigue on and off for over 7 weeks!!!
Age: 75.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Nasopharyngitis, Pain, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Finally you ask!!!! Terrible aches and fatigue on and off for over 7 weeks!!!